BioMarin Pharmaceutical | BMRN - Market Capitalization

Stock Price
51.81
Daily Change
-1.43 -2.69%
Monthly
-4.23%
Yearly
-12.59%
Q2 Forecast
50.77

BioMarin Pharmaceutical reported $10.02B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Bayer EUR 37.69B 1.01B May/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Gilead Sciences USD 167.39B 5.6B May/2026
Incyte USD 21.73B 3B May/2026
Insmed USD 15.56B 19.73B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
PTC Therapeutics USD 4.94B 698M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.16B 123M May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
United Therapeutics USD 28.08B 2.9B May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026